Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

NCT00703534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD
Acid Reflux Disease
Heartburn
Regurgitation

Interventions

DRUG: AZD3355
DRUG: Placebo
DRUG: Gelusil®

Sponsor

AstraZeneca